Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-08-06FDA Approved: LORATADINE AND PSEUDOEPHEDRINE SULFATE — Original Application (DR REDDYS)
FDA approves original application for Loratadine and Pseudoephrine Sulfate combination product (ANDA 220448) from DR REDDYS.
-
FDA approval · 2026-07-30FDA Approved: FEXOFENADINE HYDROCHLORIDE — Original Application (DR REDDYS)
FDA approval information for the original application of fexofenadine hydrochloride (generic antihistamine) by Dr. Reddy's.
-
EMA approval · 2026-07-24EMA Authorised: Desloratadine Teva (desloratadine) — Teva B.V
Desloratadine Teva has been authorised by the EMA for allergic rhinitis (perennial and seasonal).
-
EMA approval · 2026-06-05EMA Authorised: Dasselta (desloratadine) — Krka, d.d., Novo mesto
Dasselta (desloratadine) by Krka has been authorised for allergic rhinitis (perennial and seasonal) and urticaria in the EU.
-
EMA approval · 2026-04-07EMA Authorised: Aerinaze (desloratadine;pseudophedrine sulfate) — Organon N.V.
EMA authorized Aerinaze, a fixed-dose combination of desloratadine and pseudoephedrine sulfate, for allergic rhinitis with seasonal symptoms…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2026-04-03FDA Approved: PHENYLEPHRINE HYDROCHLORIDE — Original Application (Baxter Healthcare Corporation)
FDA approved Baxter Healthcare Corporation's phenylephrine hydrochloride as an original ANDA, confirming a generic version of this decongest…
-
FDA approval · 2026-03-24FDA Approved: ZYRTEC — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC (cetirizine hydrochloride) filed by Kenvue Brands LLC. This action confirms regulatory ap…
-
EMA approval · 2026-03-19EMA Authorised: Neoclarityn (desloratadine) — Organon N.V.
The EMA authorised Neoclarityn (desloratadine) by Organon N.V. for allergic rhinitis (perennial and seasonal) and urticaria.
-
EMA approval · 2026-03-19EMA Authorised: Aerius (desloratadine) — Organon N.V.
The European Medicines Agency has authorised Aerius (desloratadine), a non-sedating antihistamine for allergic rhinitis (perennial and seaso…
-
FDA approval · 2026-03-16FDA Approved: FLUTICASONE PROPIONATE ALLERGY RELIEF — Original Application (GLENMARK THERAPEUTICS INC., USA)
FDA approved Glenmark's Fluticasone Propionate Allergy Relief as a new generic nasal spray for allergic rhinitis.
-
FDA approval · 2026-03-05FDA Approved: CHILDRENS XYZAL ALLERGY — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for Children's XYZAL Allergy (levocetirizine dihydrochloride) from Chattem, Inc., signaling a la…
-
EMA approval · 2026-03-02EMA Authorised: Azomyr (desloratadine) — Organon N.V.
The European Medicines Agency authorised Azomyr, a desloratadine-containing medicine by Organon N.V., for allergic rhinitis (seasonal and pe…
-
FDA approval · 2026-02-25FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Advagen Pharma Ltd.,)
FDA approved cetirizine hydrochloride via Original Application (ANDA) for Advagen Pharma Ltd.
-
FDA approval · 2026-01-30FDA Approved: CETIRIZINE HCL — Supplemental Application (AMERISOURCE BERGEN)
The FDA approved a supplemental application for cetirizine hydrochloride, submitted by Amerisource Bergen.
-
FDA approval · 2026-01-07FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Marlex Pharmaceuticals Inc)
FDA approved a supplemental application for levocetirizine dihydrochloride from Marlex Pharmaceuticals Inc., updating the approved generic p…
-
FDA approval · 2025-12-29FDA Approved: PSEUDOEPHEDRINE HYDROCHLORIDE — Original Application (WALGREEN CO.)
FDA approved Walgreens' original application for pseudoephedrine hydrochloride as a generic drug, enabling market authorization for this dec…
-
FDA approval · 2025-12-24FDA Approved: CHILDRENS ZYRTEC — Supplemental Application (Kenvue Brands LLC)
FDA approves a supplemental application for Children's ZYRTEC (cetirizine hydrochloride) to update labeling/indications submitted by Kenvue …
-
FDA approval · 2025-12-19FDA Approved: CHILDRENS FLONASE ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Children's Flonase Allergy Relief (fluticasone propionate) from Haleon US Holdings LLC.
-
FDA approval · 2025-12-19FDA Approved: FLONASE SENSIMIST ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for Flonase Sensimist Allergy Relief (fluticasone furoate) from Haleon US Holdings LLC. The approval…
-
FDA approval · 2025-11-25FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (BAJAJ MEDICAL, LLC)
FDA approved a supplemental application for cetirizine hydrochloride from Bajaj Medical, LLC, authorizing continued marketing of the generic…
-
FDA approval · 2025-10-27FDA Approved: ASTEPRO ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for ASTEPRO ALLERGY (azelastine hydrochloride) from Bayer HealthCare LLC.
-
FDA approval · 2025-10-07FDA Approved: FOSTER AND THRIVE ALLERGY AND CONGESTION D — Original Application (Strategic Sourcing Services LLC)
FDA approved a generic fixed-dose combination product Foster and Thrive Allergy and Congestion D containing fexofenadine hydrochloride and p…
-
FDA approval · 2025-09-30FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Montelukast Sodium by Amneal Pharmaceuticals LLC. This approval relates to an updated labeling o…
-
FDA approval · 2025-08-29FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for cetirizine hydrochloride from Rising Pharma Holdings, Inc., indicating an update to the approved…
-
FDA approval · 2025-08-22FDA Approved: DIPHENHYDRAMINE HYDROCHLORIDE — Original Application (Micro Labs Limited)
FDA approved a Diphenhydramine hydrochloride product from Micro Labs Limited under Original Application (ANDA 219845). This approval covers …